Feature

Look Beyond BMI: Metabolic Factors’ Link to Cancer Explained


 

FROM CANCER

What Are the Limitations of This Research?

The researchers of the current study acknowledged the lack of information on other causes of cancer, including dietary habits, hepatitis C infection, and Helicobacter pylori infection. Other limitations include the focus only on individuals from a single community of mainly middle-aged men in China that may not generalize to other populations.

Also, the metabolic syndrome trajectories did not change much over time, which may be related to the short 4-year study period.

Using the International Diabetes Federation criteria was another limitation, because it prevented the assessment of cancer risk in normal weight individuals with metabolic dysfunction, Dr. Hardikar noted.

Does Metabolic Syndrome Cause Cancer?

“This research suggests that proactive and continuous management of metabolic syndrome may serve as an essential strategy in preventing cancer,” senior author Han-Ping Shi, MD, PhD, of Capital Medical University in Beijing, noted in a statement on the study.

More research is needed to assess the impact of these interventions on cancer risk. However, the data from the current study can guide future research that may lead to more targeted treatments and more effective preventive strategies, he continued.

“Current evidence based on this study and many other reports strongly suggests an increased risk for cancer associated with metabolic syndrome,” Dr. Hardikar said in an interview. The data serve as a reminder to clinicians to look beyond BMI as the only measure of obesity, and to consider metabolic factors together to identify individuals at increased risk for cancer, she said.

“We must continue to educate patients about obesity and all the chronic conditions it may lead to, but we cannot ignore this emerging phenotype of being of normal weight but metabolically unhealthy,” Dr. Hardikar emphasized.

What Additional Research is Needed?

Looking ahead, “we need well-designed interventions to test causality for metabolic syndrome and cancer risk, though the evidence from the observational studies is very strong,” Dr. Hardikar said.

In addition, a consensus is needed to better define metabolic dysfunction,and to explore cancer risk in normal weight but metabolically unhealthy individuals, she said.

The study was supported by the National Key Research and Development Program of China. The researchers and Dr. Hardikar had no financial conflicts to disclose.

Pages

Recommended Reading

Poor Quality of Cancer Content on Social Media
MDedge Hematology and Oncology
Are Food Emulsifiers Associated With Increased Cancer Risk?
MDedge Hematology and Oncology
What Happens to Surgery Candidates with BHDs and Cancer?
MDedge Hematology and Oncology
Tumor Microbiome Differs in Young- vs Average-Onset CRC
MDedge Hematology and Oncology
FDA Removes Harmful Chemicals From Food Packaging
MDedge Hematology and Oncology
Can Changes to Chemo Regimens Improve Drug Tolerability in Older Patients?
MDedge Hematology and Oncology
Does Exercise Reduce Cancer Risk? It’s Just Not That Simple
MDedge Hematology and Oncology
New Cancer Surgical Tech Gets Positive Vote, But Some Cite Safety Concerns
MDedge Hematology and Oncology
Higher Prostate Cancer Rates Seen in Black Men, but Advanced Cases Similar to White Men
MDedge Hematology and Oncology
Does worsening metabolic syndrome increase the risk of developing cancer?
MDedge Hematology and Oncology